Highlighted Text:
Show |
Hide
Full text loading...
Chapter 24 : In Situ Gene Amplification and Hybridization Assays: Disease Monitoring Applications Using Flow Cytometry
Author:
Bruce K. Patterson
Content Type: Reference
Publication Year:
2006
Category: Immunology
Book DOI:
10.1128/9781555815905
Chapter DOI:
10.1128/9781555815905.ch24
MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
Preview this chapter:
In Situ Gene Amplification and Hybridization Assays: Disease Monitoring Applications Using Flow Cytometry, Page 1 of 2
< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap24-1.gif /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap24-2.gif
Abstract:
The ideal situation in diagnostics would be if one could in a sensitive and specific manner detect certain disease-causing genes, including infectious agents, without destroying the cells. From a diagnostic perspective, the detection of genes and proteins within a cell would need to be high throughput on a user-friendly platform capable of an expanded menu. This chapter describes multiple approaches of performing molecular biology in a cell. It also describes how to use the assays to gain a better understanding of disease processes and ultimately how the assays can be adopted in clinical laboratories to provide the most comprehensive information on response to a variety of therapies. The powerful combination of single-copy detection in cells combined with the high-throughput cellular analysis platform of flow cytometry led to the elucidation that human immunodeficiency virus type 1 (HIV-1) infected enough cells to account for the severe immune destruction leading to AIDS. In situ self-sustained sequence replication (IS-3SR) is based on the use of primers with attached RNA polymerase initiation sites and the combination of three different enzymes in the same reaction mixture (DNA polymerase, RNase H, and RNA polymerase), resulting in accumulation of target mRNA through the combination of reverse transcription, DNA synthesis, and in vitro transcription. The development of HIV-1 entry inhibitors, most notably the CCR5 inhibitors, will present an exciting opportunity for cell-based diagnostics.
Citation:
Patterson B.
2006.
In Situ Gene Amplification and Hybridization Assays: Disease Monitoring Applications Using Flow Cytometry,
p 222-230.
In
Detrick B, Hamilton R, Folds J (ed),
Manual of Molecular and Clinical Laboratory Immunology, 7th Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815905.ch24
Key Concept Ranking
- Human immunodeficiency virus 1
- 0.5144963
- Highly Active Antiretroviral Therapy
- 0.44748107
0.5144963
Figures
In Situ Gene Amplification and Hybridization Assays: Disease Monitoring Applications Using Flow Cytometry
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815905.ch24-1,webId=/content/author/10.1128/9781555815905.ch24-1,properties={foaf_givenname=Bruce K., foaf_name=Bruce K. Patterson, foaf_surname=Patterson}]]
Citation:
Patterson B.
2006.
In Situ Gene Amplification and Hybridization Assays: Disease Monitoring Applications Using Flow Cytometry,
p 222-230.
In
Detrick B, Hamilton R, Folds J (ed),
Manual of Molecular and Clinical Laboratory Immunology, 7th Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815905.ch24
/content/10.1128/9781555815905.ch24.ch24fig01
FIGURE 1
Schematic of the HIV-1 life cycle in T lymphocytes and the ideal tests to determine the response to therapy.
10.1128/9781555815905/f0223-01_thmb.gif
10.1128/9781555815905/f0223-01.gif
FIGURE 1
Schematic of the HIV-1 life cycle in T lymphocytes and the ideal tests to determine the response to therapy.
Citation:
Patterson B.
2006.
In Situ Gene Amplification and Hybridization Assays: Disease Monitoring Applications Using Flow Cytometry,
p 222-230.
In
Detrick B, Hamilton R, Folds J (ed),
Manual of Molecular and Clinical Laboratory Immunology, 7th Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815905.ch24
/content/10.1128/9781555815905.ch24.ch24fig02
FIGURE 2
Representative dot plot of simultaneous immunophenotyping for CD4 and real-time PCR in situ (FISNA) detecting cells containing HIV-1 DNA. Biotinylated or 2,4-dinitrophenol (DNP)-conjugated antibodies survive the thermocycling process (
30
).
10.1128/9781555815905/f0224-01_thmb.gif
10.1128/9781555815905/f0224-01.gif
FIGURE 2
Representative dot plot of simultaneous immunophenotyping for CD4 and real-time PCR in situ (FISNA) detecting cells containing HIV-1 DNA. Biotinylated or 2,4-dinitrophenol (DNP)-conjugated antibodies survive the thermocycling process ( 30 ).
Citation:
Patterson B.
2006.
In Situ Gene Amplification and Hybridization Assays: Disease Monitoring Applications Using Flow Cytometry,
p 222-230.
In
Detrick B, Hamilton R, Folds J (ed),
Manual of Molecular and Clinical Laboratory Immunology, 7th Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815905.ch24
/content/10.1128/9781555815905.ch24.ch24fig03
FIGURE 3
Representative laser confocal image analysis of real-time PCR in situ (FISNA) detecting cells in the prostate containing HIV-1 DNA following long-term therapy with antiretroviral drugs. These data suggest that reservoirs of HIV-1 DNA-containing cells are not necessarily cleared by long-term therapy (
26
).
10.1128/9781555815905/f0225-01_thmb.gif
10.1128/9781555815905/f0225-01.gif
FIGURE 3
Representative laser confocal image analysis of real-time PCR in situ (FISNA) detecting cells in the prostate containing HIV-1 DNA following long-term therapy with antiretroviral drugs. These data suggest that reservoirs of HIV-1 DNA-containing cells are not necessarily cleared by long-term therapy ( 26 ).
Citation:
Patterson B.
2006.
In Situ Gene Amplification and Hybridization Assays: Disease Monitoring Applications Using Flow Cytometry,
p 222-230.
In
Detrick B, Hamilton R, Folds J (ed),
Manual of Molecular and Clinical Laboratory Immunology, 7th Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815905.ch24
/content/10.1128/9781555815905.ch24.ch24fig04
FIGURE 4
Monitoring HIV-1 replication in patients on highly active antiretroviral therapy by simultaneous immunophenotyping and ultrasensitive fluorescence in situ hybridization in T lymphocytes (CD4+ CD45RO+) and in monocytes/macrophages (CD14/CD16).
10.1128/9781555815905/f0226-01_thmb.gif
10.1128/9781555815905/f0226-01.gif
FIGURE 4
Monitoring HIV-1 replication in patients on highly active antiretroviral therapy by simultaneous immunophenotyping and ultrasensitive fluorescence in situ hybridization in T lymphocytes (CD4+ CD45RO+) and in monocytes/macrophages (CD14/CD16).
Citation:
Patterson B.
2006.
In Situ Gene Amplification and Hybridization Assays: Disease Monitoring Applications Using Flow Cytometry,
p 222-230.
In
Detrick B, Hamilton R, Folds J (ed),
Manual of Molecular and Clinical Laboratory Immunology, 7th Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815905.ch24
/content/10.1128/9781555815905.ch24.ch24fig05
FIGURE 5
Combining plasma viral load (pVL) and simultaneous immunophenotyping and ultrasensitive fluorescence in situ hybridization in T lymphocytes (CD4+ CD45RO+) and in monocytes/macrophages (CD14/CD16) to determine response of multiple tissue compartments to highly active antiretroviral therapy. This extremely powerful test bundle identifies individuals with a maximal response to therapy in all compartments (left) and those individuals with persistent viral replication (in cells) despite undetectable plasma viral load (right). As one might predict for an individual with persistent viral replication, plasma viral load increased during the course of therapy.
10.1128/9781555815905/f0226-02_thmb.gif
10.1128/9781555815905/f0226-02.gif
FIGURE 5
Combining plasma viral load (pVL) and simultaneous immunophenotyping and ultrasensitive fluorescence in situ hybridization in T lymphocytes (CD4+ CD45RO+) and in monocytes/macrophages (CD14/CD16) to determine response of multiple tissue compartments to highly active antiretroviral therapy. This extremely powerful test bundle identifies individuals with a maximal response to therapy in all compartments (left) and those individuals with persistent viral replication (in cells) despite undetectable plasma viral load (right). As one might predict for an individual with persistent viral replication, plasma viral load increased during the course of therapy.
Citation:
Patterson B.
2006.
In Situ Gene Amplification and Hybridization Assays: Disease Monitoring Applications Using Flow Cytometry,
p 222-230.
In
Detrick B, Hamilton R, Folds J (ed),
Manual of Molecular and Clinical Laboratory Immunology, 7th Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815905.ch24
/content/10.1128/9781555815905.ch24.ch24fig06
FIGURE 6
Simultaneous detection of the HIV-1 coreceptor CCR5 and HIV-1 replication. This combination can be used to monitor response to HIV-1 entry and CCR5 inhibitors. Combining this with CXCR4 in a third color will allow the monitoring of potential tropism shifts.
10.1128/9781555815905/f0227-01_thmb.gif
10.1128/9781555815905/f0227-01.gif
FIGURE 6
Simultaneous detection of the HIV-1 coreceptor CCR5 and HIV-1 replication. This combination can be used to monitor response to HIV-1 entry and CCR5 inhibitors. Combining this with CXCR4 in a third color will allow the monitoring of potential tropism shifts.
Citation:
Patterson B.
2006.
In Situ Gene Amplification and Hybridization Assays: Disease Monitoring Applications Using Flow Cytometry,
p 222-230.
In
Detrick B, Hamilton R, Folds J (ed),
Manual of Molecular and Clinical Laboratory Immunology, 7th Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815905.ch24
/content/10.1128/9781555815905.ch24.ch24fig07
FIGURE 7
In situ detection of HPV E6 and E7 mRNA in cervical cytology samples from women with highgrade squamous intraepithelial lesions (HSIL) and women without cytologic abnormalities (WNL). The difference in the percentage of E6 and E7 mRNA-expressing cells is highly statistically significant (
24
).
10.1128/9781555815905/f0228-01_thmb.gif
10.1128/9781555815905/f0228-01.gif
FIGURE 7
In situ detection of HPV E6 and E7 mRNA in cervical cytology samples from women with highgrade squamous intraepithelial lesions (HSIL) and women without cytologic abnormalities (WNL). The difference in the percentage of E6 and E7 mRNA-expressing cells is highly statistically significant ( 24 ).
Citation:
Patterson B.
2006.
In Situ Gene Amplification and Hybridization Assays: Disease Monitoring Applications Using Flow Cytometry,
p 222-230.
In
Detrick B, Hamilton R, Folds J (ed),
Manual of Molecular and Clinical Laboratory Immunology, 7th Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815905.ch24
/content/10.1128/9781555815905.ch24.ch24fig08
FIGURE 8
Ultrasensitive fluorescence in situ hybridization detection of HPV E6 and E7 mRNA expression in liquid-based cervical cytology samples. Hybrid Capture II high-risk HPV-positive samples (top row) and Hybrid Capture II high-risk HPV-negative samples were hybridized and run on a Guava Technologies PCA-96 capillary cytometer.
10.1128/9781555815905/f0228-02_thmb.gif
10.1128/9781555815905/f0228-02.gif
FIGURE 8
Ultrasensitive fluorescence in situ hybridization detection of HPV E6 and E7 mRNA expression in liquid-based cervical cytology samples. Hybrid Capture II high-risk HPV-positive samples (top row) and Hybrid Capture II high-risk HPV-negative samples were hybridized and run on a Guava Technologies PCA-96 capillary cytometer.
Citation:
Patterson B.
2006.
In Situ Gene Amplification and Hybridization Assays: Disease Monitoring Applications Using Flow Cytometry,
p 222-230.
In
Detrick B, Hamilton R, Folds J (ed),
Manual of Molecular and Clinical Laboratory Immunology, 7th Edition.
ASM Press, Washington, DC.
doi: 10.1128/9781555815905.ch24
References
/content/book/10.1128/9781555815905.ch24
1.
Al-Harthi, L.,, J. Voris,, B. K. Patterson,, S. Becker,, J. Eron,, K. Y. Smith,, R. D’Amico,, D. Mildvan,, J. Snidow,, B. Pobiner,, L. Yau, and , A. Landay. 2004. Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients. HIV Med. 5: 55– 65.
2.
Behbahani, H.,, A. Landay,, B. K. Patterson,, P. Jones,, J. Pottage,, M. Agnoli,, J. Andersson, and , A. L. Spetz. 2000. Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy. J. Acquir. Immune. Defic. Syndr. 25: 150– 156.
3.
Behbahani, H.,, E. Popek,, P. Garcia,, J. Andersson,, A. L. Spetz,, A. Landay,, Z. Flener, and , B. K. Patterson. 2000. Upregulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission. Am. J. Pathol. 157: 1811– 1818.
4.
Brodie, S. J.,, D. A. Lewinsohn,, B. K. Patterson,, D. Jiyamapa,, J. Krieger,, L. Corey,, P. D. Greenberg, and , S. R. Riddell. 1999. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat. Med. 5: 34– 41.
5.
Collins, K. B.,, B. K. Patterson,, G. J. Naus,, D. V. Landers, and , P. Gupta. 2000. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat. Med. 6: 475– 479.
6.
Connor, R. I.,, K. E. Sheridan,, D. Ceradini,, S. Choe, and , N. R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185: 621– 628.
7.
Crouch, J.,, D. Leitenberg,, B. R. Smith, and , J. G. Howe. 1997. Epstein-Barr virus suspension cell assay using in situ hybridization and flow cytometry. Cytometry 29: 50– 57.
8.
Doherty, T. M.,, C. Chougnet,, M. Schito,, B. K. Patterson,, C. Fox,, G. M. Shearer,, G. Englund, and , A. Sher. 1999. Infection of HIV-1 transgenic mice with Mycobacterium avium induces the expression of infectious virus selectively from a Mac-1-positive host cell population. J. Immunol. 163: 1506– 1515.
9.
Dyson, N.,, P. M. Howley,, K. Munger, and , E. Harlow. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934– 937.
10.
Embretson, J.,, M. Zupancic,, J. Beneke,, M. Till,, S. Wolinsky,, J. L. Ribas,, A. Burke, and , A. T. Haase. 1993. Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc. Natl. Acad. Sci. USA 90: 357– 361.
11.
Furtado, M. R.,, D. S. Callaway,, J. P. Phair,, K. J. Kunstman,, J. L. Stanton,, C. A. Macken,, A. S. Perelson, and , S. M. Wolinsky. 1999. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N. Engl. J. Med. 340: 1614– 1622.
12.
Gibellini, D. E.,, M. C. Re,, G. Furlini, and , P. M. LaPlaca. 1997. Flow cytometry analysis of an in situ PCR for the detection of human immunodeficiency virus type-1 (HIV-1) proviral DNA. Methods Mol. Biol. 71: 113– 122.
13.
Gupta, P.,, K. B. Collins,, D. Ratner,, S. Watkins,, G. J. Naus,, D. V. Landers, and , B. K. Patterson. 2002. Memory CD4+ T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J. Virol. 76: 9868– 9876.
14.
Havlir, D. V.,, M. C. Strain,, M. Clerici,, C. Ignacio,, D. Trabattoni,, P. Ferrante, and , J. K. Wong. 2003. Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years. J. Virol. 77: 11212– 11219.
15.
Janes, M. S.,, B. J. Hanson,, D. M. Hill,, G. M. Buller,, J. Y. Agnew,, S. W. Sherwood,, W. G. Cox,, K. Yamagata, and , R. A. Capaldi. 2004. Rapid analysis of mitochondrial DNA depletion by fluorescence in situ hybridization and immunocytochemistry: potential strategies for HIV therapeutic monitoring. J. Histochem. Cytochem. 52: 1011– 1018.
16.
Koffron, A. J.,, M. Hummel,, B. K. Patterson,, S. Yan,, D. B. Kaufman,, J. P. Fryer,, F. P. Stuart, and , M. I. Abecassis. 1998. Cellular localization of latent murine cytomegalovirus. J. Virol 72: 95– 103.
17.
Komminoth, P.,, A. A. Long,, R. Ray, and , H. J. Wolfe. 1992. In situ polymerase chain reaction detection of viral DNA, single-copy genes, and gene rearrangements in cell suspensions and cytospins. Diagn. Mol. Pathol. 1: 85– 97.
18.
Komminoth, P., and , M. Werner. 1997. Target and signal amplification: approaches to increase the sensitivity of in situ hybridization. Histochem. Cell Biol. 108: 325– 333.
19.
Korber, B. T.,, K. J. Kunstman,, B. K. Patterson,, M. Furtado,, M. M. McEvilly,, R. Levy, and , S. M. Wolinsky. 1994. Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brainderived sequences. J. Virol 68: 7467– 7481.
20.
Lalli, E.,, D. Gibellini,, S. Santi, and , A. Facchini. 1992. In situ hybridization in suspension and flow cytometry as a tool for the study of gene expression. Anal. Biochem. 207: 298– 303.
21.
Lange, C. G.,, Z. Xu,, B. K. Patterson,, K. Medvik,, B. Harnisch,, R. Asaad,, H. Valdez,, S. J. Lee,, A. Landay,, J. Lieberman, and , M. M. Lederman. 2004. Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function. AIDS 18: 605– 613.
22.
Lizard, G.,, M. C. Chignol,, Y. Chardonnet,, C. Souchier,, M. Bordes,, D. Schmitt, and , J. P. Revillard. 1993. Detection of human papillomavirus DNA in CaSki and HeLa cells by fluorescent in situ hybridization. Analysis by flow cytometry and confocal laser scanning microscopy. J. Immunol. Methods 157: 31– 38.
23.
Lore, K.,, A. Sonnerborg,, J. Olsson,, B. K. Patterson,, T. E. Fehniger,, L. Perbeck, and , J. Andersson. 1999. HIV-1 exposed dendritic cells show increased pro-inflammatory cytokine production but reduced IL-1ra following lipopolysaccharide stimulation. AIDS 13: 2013– 2021.
24.
Narimatsu, R., and , B. K. Patterson. 2005. High-throughput cervical cancer screening using intracellular human papillomavirus E6 and E7 mRNA quantification by flow cytometry. Am J. Clin. Pathol. 123: 716– 723.
25.
Nuovo, G. J.,, G. A. Gorgone,, P. MacConnell,, M. Margiotta, and , P. D. Gorevic. 1992. In situ localization of PCR-amplified human and viral cDNAs. PCR Methods Applic. 2: 117– 123.
26.
Paranjpe, S.,, J. Craigo,, B. Patterson,, M. Ding,, P. Barroso,, L. Harrison,, R. Montelaro, and , P. Gupta. 2002. Subcompartmentalization of HIV-1 quasispecies between seminal cells and seminal plasma indicates their origin in distinct genital tissues. AIDS Res. Hum. Retrovir. 18: 1271– 1280.
27.
Patterson, B. K. (ed.). 2000. Techniques in the Quantitative Localization of Gene Expression. Springer-Verlag, New York, N.Y.
28.
Patterson, B. K.,, D. J. Carlo,, M. H. Kaplan,, M. Marecki,, S. Pawha, and , R. B. Moss. 1999. Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytes in asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1 immunogen. AIDS 13: 1607– 1611.
29.
Patterson, B. K.,, M. A. Czerniewski,, J. Pottage,, M. Agnoli,, H. Kessler, and , A. Landay. 1999. Monitoring HIV-1 treatment in immune-cell subsets with ultrasensitive fluorescence-in-situ hybridisation. Lancet 353: 211– 212.
30.
Patterson, B. K.,, C. Goolsby,, V. Hodara,, K. L. Lohman, and , S. M. Wolinsky. 1995. Detection of CD4+ T cells harboring human immunodeficiency virus type 1 DNA by flow cytometry using simultaneous immunophenotyping and PCR-driven in situ hybridization: evidence of epitope masking of the CD4 cell surface molecule in vivo. J. Virol. 69: 4316– 4322.
31.
Patterson, B. K.,, D. Jiyamapa,, E. Mayrand,, B. Hoff,, R. Abramson, and , R M. Garcia. 1996. Detection of HIV-1 DNA in cells and tissue by fluorescent in situ 5’-nuclease assay (FISNA). Nucleic Acids Res. 24: 3656– 3658.
32.
Patterson, B. K.,, S. McCallister,, M. Schutz,, J. N. Siegel,, K. Shults,, Z. Flener, and , A. Landay. 2001. Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART. AIDS 15: 1635– 1641.
33.
Patterson, B. K.,, V. L. Mosiman,, L. Cantarero,, M. Furtado,, M. Bhattacharya, and , C. Goolsby. 1998. Detection of HIV-RNA-positive monocytes in peripheral blood of HIV-positive patients by simultaneous flow cytometric analysis of intracellular HIV RNA and cellular immunophenotype. Cytometry 31: 265– 274.
34.
Patterson, B. K.,, M. Till,, P. Otto,, C. Goolsby,, M. R. Furtado,, L. J. McBride, and , S. M. Wolinsky. 1993. Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 260: 976– 979.
35.
Player, A. N.,, L. P. Shen,, D. Kenny,, V. P. Antao, and , J. A. Kolberg. 2001. Single-copy gene detection using branched DNA (bDNA) in situ hybridization. J. Histochem. Cytochem. 49: 603– 612.
36.
Qian, X., and , R. V. Lloyd. 2003. Recent developments in signal amplification methods for in situ hybridization. Diagn. Mol. Pathol. 12: 1– 13.
37.
Re, M. C.,, G. Furlini,, D. Gibellini,, M. Vignoli,, E. Ramazzotti,, E. Lolli,, S. Ranieri, and , P. M. La. 1994. Quantification of human immunodeficiency virus type 1-infected mononuclear cells in peripheral blood of seropositive subjects by newly developed flow cytometry analysis of the product of an in situ PCR assay. J. Clin. Microbiol. 32: 2152– 2157.
38.
Rochet, V.,, L. Rigottier-Gois,, S. Rabot, and , J. Dore. 2004. Validation of fluorescent in situ hybridization combined with flow cytometry for assessing interindividual variation in the composition of human fecal microflora during long-term storage of samples. J. Microbiol. Methods 59: 263– 270.
39.
Scheffner, M.,, B. A. Werness,, J. M. Huibregtse,, A. J. Levine, and , P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129– 1136.
40.
Spetz, A. L.,, B. K. Patterson,, K. Lore,, J. Andersson, and , L. Holmgren. 1999. Functional gene transfer of HIV DNA by an HIV receptor-independent mechanism. J. Immunol. 163: 736– 742.
41.
Spira, A. I.,, P. A. Marx,, B. K. Patterson,, J. Mahoney,, R. A. Koup,, S. M. Wolinsky, and , D. D. Ho. 1996. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183: 215– 225.
42.
Stowe, R. P.,, M. L. Cubbage,, C. F. Sams,, D. L. Pierson, and , A. D. Barrett. 1998. Detection and quantification of Epstein-Barr virus EBER1 in EBV-infected cells by fluorescent in situ hybridization and flow cytometry. J. Virol. Methods 75: 83– 91.
43.
Wilkens, L.,, J. Tchinda,, P. Komminoth, and , M. Werner. 1997. Single- and double-color oligonucleotide primed in situ labeling (PRINS): applications in pathology. Histochem. Cell Biol. 108: 439– 446.
44.
Zhang, L.,, B. Ramratnam,, K. Tenner-Racz,, Y. He,, M. Vesanen,, S. Lewin,, A. Talal,, P. Racz,, A. S. Perelson,, B. T. Korber,, M. Markowitz, and , D. D. Ho. 1999. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N. Engl. J. Med. 340: 1605– 1613.